Design (Testphase)
Aktien.Guide
Quality Stocks
23
Hits
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Sixfold quality filter: return on equity above 20%, equity ratio above 25%, free cash flow margin above 25% (last 4 quarters), revenue growth above 10%, P/E below 30, and market cap above $2B. Highly profitable, solidly financed, growing — and not overpriced. Source: fundamental data.
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
🔔 Watch scanner
Terms in This Scanner Explained
(15)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MU Micron Technology Inc | — | +511 % | 97 12/25 | Stage 2 | A 92 | 6 of 9 | 1,069.1 $ | Semiconductors | Sells AI | — | Technology | 823.00 $ | +268.7 % | +299.8 % | +655.3 % | −3.3 % | +85.0 % | 99 | 96 | 10.6 % | 9.5 % | 2.14 | 17.4 | 5.3 | 18.4 | 8.6 | 27.2 | 0.12 | 13.3 | 80.4 % | 72.6 % | 55.9 % | 39.8 % | 34.9 % | 0.06 | 75.1 % | +48.9 % | — | 0.1 % | 1.2 % | 11.7 | 81.6 % | 3.2 % | 4.5 (37) | |
| ADEA ADEIA CORP | 08/04 | +69 % | 34 4/25 | Stage 2 | B 64 | 8 of 9 | 3.1 $ | Software - Application | Uses AI | — | — | Technology | 26.70 $ | +76.9 % | +91.0 % | +108.1 % | −11.5 % | +38.6 % | 91 | 85 | 6.3 % | 7.2 % | 0.94 | 24.9 | 19.5 | 6.7 | 6.3 | 20.5 | 1.51 | 12.7 | 39.0 % | 100.0 % | 26.5 % | 28.5 % | 12.7 % | 0.06 | 46.6 % | +17.9 % | — | 0.8 % | 13.2 % | 7.1 | 101.2 % | 13.1 % | 4.3 (3) |
| SEZL Sezzle Inc. | 08/06 | — | 70 6/22 | Stage 2 | A 76 | 6 of 9 | 5.4 $ | Credit Services | Uses AI | — | Financial Services | 154.80 $ | +138.8 % | +131.8 % | -0.1 % | −12.3 % | +5.7 % | 91 | 76 | 8.0 % | 7.4 % | 6.72 | 22.2 | 30.3 | 11.2 | 15.9 | 22.5 | 0.11 | 28.5 | 61.0 % | 74.3 % | 30.8 % | 92.0 % | 47.5 % | 0.74 | 43.3 % | +66.1 % | — | 0.0 % | 0.0 % | 11.4 | 40.9 % | 23.2 % | 5.0 (2) | |
| AMG Affiliated Managers Group, Inc. | 07/30 | +48 % | 68 6/22 | Stage 2 | B 65 | 7 of 9 | 9.9 $ | Asset Management | Threatened | — | — | Financial Services | 366.70 $ | +21.5 % | +17.6 % | +74.8 % | −6.5 % | +17.0 % | 82 | 82 | 2.7 % | 3.1 % | 1.12 | 15.1 | 10.5 | 4.2 | 3.1 | 9.2 | 0.93 | 7.3 | 22.1 % | 50.3 % | 37.7 % | 21.8 % | 3.4 % | 0.95 | 32.9 % | +19.8 % | — | 0.0 % | 0.1 % | 7.7 | 98.8 % | 4.5 % | 4.0 (7) |
| CPRX Catalyst Pharmaceuticals Inc | 08/05 | +46 % | 68 6/22 | Stage 2 | B 64 | 6 of 9 | 3.9 $ | Biotechnology | – | — | — | Healthcare | 31.50 $ | +34.5 % | +28.7 % | +46.8 % | −3.5 % | +0.5 % | 81 | 59 | 0.1 % | 0.2 % | 0.74 | 18.3 | 13.0 | 6.5 | 3.8 | 18.5 | — | 10.1 | 49.0 % | 84.0 % | 37.1 % | 24.5 % | 16.3 % | 0.00 | 88.2 % | +19.8 % | — | 0.0 % | 0.0 % | 19.0 | 89.8 % | 6.8 % | 4.9 (7) |
| HG Hamilton Insurance Group, Ltd. | 08/05 | — | 99 12/22 | Stage 2 | B 61 | 7 of 9 | 3.6 $ | Insurance - Reinsurance | Uses AI | — | Financial Services | 36.00 $ | +29.6 % | +33.8 % | +79.1 % | 0 % | -0.4 % | 74 | 82 | 2.8 % | 2.7 % | 0.46 | 5.7 | 0.0 | 1.2 | 1.3 | 3.9 | — | 0.0 | 29.1 % | 40.5 % | 21.7 % | 33.7 % | 6.0 % | 0.05 | 29.5 % | +15.3 % | — | 6.6 % | 44.5 % | 0.8 | 83.6 % | 3.0 % | 3.8 (6) | |
| UTHR United Therapeutics Corporation | 07/29 | +48 % | 88 8/22 | Stage 2 | C 54 | 5 of 9 | 22.0 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 517.70 $ | +11.7 % | +5.9 % | +88.5 % | −10.8 % | +28.1 % | 71 | 26 | 2.4 % | 2.3 % | 0.58 | 19.1 | 18.8 | 6.9 | 3.7 | 21.6 | 2.22 | 11.0 | 41.7 % | 86.6 % | 40.6 % | 20.3 % | 12.6 % | — | 87.9 % | +10.6 % | — | 0.0 % | 0.0 % | 19.0 | 102.1 % | 5.8 % | 4.4 (15) |
| EVR Evercore Partners Inc | 07/29 | +76 % | 12 2/22 | Stage 2 | A 80 | 7 of 9 | 12.4 $ | Capital Markets | Neutral | — | — | Financial Services | 320.60 $ | +8.3 % | -4.0 % | +7.6 % | −10.7 % | +15.1 % | 70 | 86 | 3.9 % | 3.7 % | 1.49 | 17.8 | 17.4 | 2.7 | 6.8 | 8.1 | 1.64 | 6.3 | 24.4 % | 93.9 % | 15.8 % | 42.2 % | 21.3 % | 0.71 | 41.3 % | +29.5 % | — | 1.1 % | 18.2 % | 11.1 | 94.1 % | 3.1 % | 4.0 (11) |
| AU AngloGold Ashanti plc | 08/07 | +103 % | 11 2/23 | Stage 1 | A 80 | 8 of 9 | 41.3 $ | Gold | Neutral | — | — | Basic Materials | 79.30 $ | +1.1 % | -6.4 % | +81.0 % | −38.6 % | +43.9 % | 66 | 90 | 5.7 % | 5.6 % | 0.67 | 11.6 | 10.0 | 3.7 | 4.7 | 10.3 | 0.78 | 6.1 | 56.1 % | 54.8 % | 32.2 % | 43.0 % | 24.9 % | 0.27 | 54.4 % | +70.8 % | — | 5.7 % | 58.6 % | 10.2 | 80.6 % | 1.3 % | 3.4 (8) |
| INCY Incyte Corporation | 08/04 | +22 % | 88 8/22 | Stage 2 | A 77 | 7 of 9 | 23.7 $ | Biotechnology | Uses AI | — | Healthcare | 119.50 $ | +5.7 % | +14.2 % | +59.6 % | −4.2 % | +2.9 % | 66 | 83 | 4.3 % | 3.7 % | 0.76 | 17.9 | 38.5 | 4.4 | 4.5 | 16.3 | 28.47 | 9.5 | 25.6 % | 55.7 % | 27.7 % | 30.8 % | 16.8 % | 0.01 | 75.6 % | +21.2 % | — | 0.0 % | 0.0 % | 11.9 | 106.6 % | 9.1 % | 3.7 (27) | |
| NBIX Neurocrine Biosciences Inc | 07/29 | +23 % | 67 6/22 | Stage 2 | A 77 | 6 of 9 | 16.8 $ | Drug Manufacturers - Specialty & Generic | Uses AI | — | Healthcare | 166.80 $ | +13.8 % | +15.7 % | +30.1 % | −3.2 % | +26.6 % | 65 | 98 | 2.9 % | 2.9 % | 0.39 | 26.3 | 23.5 | 5.0 | 4.9 | 19.3 | 0.47 | 18.2 | 22.8 % | 64.5 % | 20.9 % | 22.5 % | 11.7 % | 0.12 | 69.5 % | +21.5 % | — | 0.0 % | 0.0 % | 9.4 | 103.9 % | 6.9 % | 4.5 (25) | |
| NEM Newmont Goldcorp Corp | 07/23 | +51 % | 22 3/23 | Stage 1 | B 73 | 9 of 9 | 100.0 $ | Gold | Neutral | — | — | Basic Materials | 93.70 $ | -1.6 % | -9.4 % | +52.5 % | −29.3 % | +38.0 % | 60 | 83 | 4.4 % | 4.4 % | 0.48 | 12.1 | 10.3 | 3.9 | 2.9 | 7.4 | 2.78 | 5.9 | 61.4 % | 68.0 % | 33.4 % | 25.8 % | 15.8 % | 0.17 | 60.6 % | +19.1 % | — | 1.1 % | 11.1 % | 7.7 | 81.3 % | 2.2 % | 4.4 (22) |
| MC Moelis & Co | 07/23 | +27 % | 26 3/22 | Stage 2 | B 57 | 3 of 9 | 5.0 $ | Capital Markets | – | — | — | Financial Services | 67.10 $ | -0.1 % | -9.8 % | -0.5 % | −16.3 % | +6.3 % | 51 | 22 | 4.0 % | 3.9 % | 1.85 | 23.8 | 20.3 | 3.3 | 10.1 | 12.0 | 1.97 | 16.5 | 12.7 % | 92.3 % | 14.5 % | 41.8 % | 18.7 % | 0.55 | 37.8 % | +27.0 % | — | 3.9 % | 88.4 % | 2.8 | 111.2 % | 6.7 % | 2.6 (8) |
| PIPR Piper Sandler Companies | 08/07 | +54 % | 38 4/22 | Stage 4 | B 67 | 6 of 9 | 5.2 $ | Capital Markets | – | — | — | Financial Services | 75.80 $ | -3.7 % | -15.1 % | -1.4 % | −79.6 % | +14.9 % | 42 | 52 | 3.3 % | 3.1 % | 1.43 | 18.7 | 10.1 | 2.6 | 3.7 | 9.2 | 1.26 | 0.0 | 21.8 % | 91.8 % | 14.5 % | 22.2 % | 16.5 % | 0.08 | 63.0 % | +28.6 % | — | 1.1 % | 42.4 % | 10.3 | 87.4 % | 5.6 % | 3.0 (4) |
| ACGL Arch Capital Group Ltd. | 07/28 | +12 % | 99 12/22 | Stage 1 | B 56 | 8 of 9 | 34.5 $ | Insurance - Diversified | Uses AI | — | — | Financial Services | 100.50 $ | -2.3 % | +1.7 % | +16.8 % | −8.8 % | +11.1 % | 36 | 85 | 2.1 % | 2.1 % | 0.29 | 8.0 | 10.7 | 1.8 | 1.6 | 5.9 | 1.05 | 0.0 | 25.3 % | 38.8 % | 24.4 % | 21.3 % | 4.1 % | 0.12 | 29.7 % | +14.3 % | — | 0.0 % | 0.0 % | 4.0 | 94.9 % | 3.0 % | 3.8 (20) |
| QLYS Qualys Inc | 08/04 | -3 % | 73 7/25 | Stage 3 | B 64 | 8 of 9 | 4.9 $ | Software - Infrastructure | – | — | — | Technology | 144.80 $ | -15.5 % | -8.0 % | +8.8 % | −25.3 % | -9.4 % | 28 | 59 | 5.0 % | 4.7 % | 0.61 | 27.6 | 19.3 | 7.2 | 9.5 | 17.0 | 5.68 | 19.2 | 35.0 % | 83.2 % | 29.4 % | 37.7 % | 13.9 % | 0.09 | 52.1 % | +10.1 % | — | 0.0 % | 0.0 % | 6.6 | 109.1 % | 15.0 % | 3.2 (23) |
| RRC Range Resources Corp | 07/28 | +12 % | 78 3/10 | Stage 1 | B 72 | 8 of 9 | 9.5 $ | Oil & Gas E&P | Neutral | — | Energy | 40.10 $ | +4.7 % | +3.6 % | +10.4 % | −24.8 % | +13.2 % | 26 | 92 | 2.6 % | 2.7 % | 0.41 | 10.6 | 11.0 | 2.8 | 2.1 | 7.0 | 1.45 | 6.7 | 44.3 % | 52.1 % | 26.3 % | 21.1 % | 10.5 % | 0.21 | 62.2 % | +27.6 % | — | 1.0 % | 10.4 % | 5.6 | 99.3 % | 11.5 % | 3.5 (26) | |
| PLMR Palomar Holdings Inc | 08/03 | +31 % | 88 8/22 | Stage 4 | B 66 | 6 of 9 | 3.6 $ | Insurance - Property & Casualty | – | — | — | Financial Services | 133.80 $ | -13.9 % | -7.1 % | +1.0 % | −27.0 % | +22.6 % | 24 | 42 | 3.9 % | 3.9 % | 0.41 | 20.0 | 0.0 | 3.6 | 4.0 | 9.8 | — | 0.0 | 20.3 % | 28.7 % | 20.1 % | 22.5 % | 5.3 % | 0.31 | 26.6 % | +58.2 % | — | 0.0 % | 0.0 % | 6.5 | 100.6 % | 5.1 % | 4.1 (8) |
| DUOL Duolingo Inc | 08/05 | -2 % | 79 8/25 | Stage 3 | A 77 | 4 of 9 | 6.0 $ | Software - Application | Sells AI | — | Technology | 134.80 $ | -24.7 % | -35.8 % | -61.1 % | −74.4 % | -14.8 % | 16 | 68 | 6.5 % | 6.5 % | 0.88 | 16.1 | 20.0 | 5.5 | 5.0 | 14.5 | — | 29.9 | 15.4 % | 72.7 % | 38.4 % | 37.0 % | 5.9 % | 0.07 | 67.6 % | +38.7 % | — | 0.0 % | 0.0 % | 9.6 | 98.5 % | 21.4 % | 3.9 (23) | |
| KNSL Kinsale Capital Group Inc | 07/23 | -5 % | 68 6/22 | Stage 4 | B 60 | 7 of 9 | 8.2 $ | Insurance - Property & Casualty | – | — | — | Financial Services | 356.40 $ | -22.0 % | -16.2 % | -18.9 % | −39.9 % | -1.9 % | 14 | 70 | 3.8 % | 3.5 % | 0.90 | 15.7 | 17.3 | 4.1 | 4.2 | 8.2 | 1.15 | 0.0 | 30.6 % | 31.1 % | 28.5 % | 29.7 % | 7.6 % | 0.11 | 31.7 % | +18.0 % | — | 0.3 % | 3.9 % | 4.8 | 97.4 % | 12.5 % | 3.5 (11) |
| PTC PTC Inc | 07/29 | -7 % | 45 5/25 | Stage 4 | B 66 | 8 of 9 | 16.2 $ | Software - Application | Sells AI | — | Technology | 137.20 $ | -35.5 % | -35.5 % | -36.1 % | −48.8 % | +26.3 % | 8 | 92 | 3.8 % | 4.0 % | 0.99 | 13.6 | 15.9 | 5.5 | 4.2 | 17.3 | 1.28 | 9.9 | 41.6 % | 84.5 % | 41.4 % | 34.4 % | 11.5 % | 3.02 | 59.0 % | +19.2 % | — | 0.0 % | 0.0 % | 8.1 | 104.3 % | 8.3 % | 4.2 (20) | |
| ADBE Adobe Systems Incorporated | — | -20 % | 77 8/25 | Stage 4 | B 63 | 5 of 9 | 98.3 $ | Software - Application | – | — | — | Technology | 250.40 $ | -43.6 % | -41.5 % | -30.0 % | −50.7 % | +7.7 % | 7 | 57 | 4.0 % | 4.4 % | 1.43 | 15.0 | 10.3 | 3.9 | 9.1 | 9.2 | 0.68 | 10.0 | 35.3 % | 89.4 % | 28.7 % | 62.9 % | 19.9 % | -2.80 | 38.5 % | +10.5 % | — | 0.0 % | 0.0 % | 10.6 | 88.1 % | 5.7 % | 4.2 (38) |
| INTU Intuit Inc | 08/20 | -14 % | 72 7/25 | Stage 4 | B 70 | 8 of 9 | 86.9 $ | Software - Application | – | — | — | Technology | 316.10 $ | -60.9 % | -60.3 % | -59.3 % | −68.7 % | +44.4 % | 2 | 59 | 4.6 % | 5.8 % | 1.00 | 20.3 | 11.6 | 4.2 | 4.2 | 11.3 | 0.82 | 12.3 | 47.0 % | 80.8 % | 21.9 % | 22.5 % | 9.5 % | 1.04 | 52.4 % | +15.6 % | — | 1.5 % | 22.1 % | 8.3 | 92.6 % | 6.6 % | 4.5 (34) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Sixfold quality filter: return on equity above 20%, equity ratio above 25%, free cash flow margin above 25% (last 4 quarters), revenue growth above 10%, P/E below 30, and market cap above $2B. Highly profitable, solidly financed, growing — and not overpriced. Source: fundamental data.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 23 stocks pass this scanner's criteria (as of 3. August 2026).
No global trading filters — this strategy checks the entire stock universe purely against its own criteria (mega caps over $50B included).
Related scanners
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.